Charles Schwab Investment Management Inc Akoya Biosciences, Inc. Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 171,776 shares of AKYA stock, worth $401,955. This represents 0.0% of its overall portfolio holdings.

Number of Shares

171,776

Previous 204,849 16.15%

Holding current value

$401,955

Previous $999,000 19.42%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$4.33 - $6.06 $143,206 - $200,422	-33,073 Reduced 16.15%	171,776 $805,000
Q4 2023 Feb 06, 2024	BUY	$3.13 - $5.13 $160,913 - $263,733	51,410 Added 33.51%	204,849 $999,000
Q3 2023 Nov 08, 2023	BUY	$4.24 - $7.44 $98,079 - $172,102	23,132 Added 17.75%	153,439 $713,000
Q2 2023 Aug 09, 2023	BUY	$5.28 - $8.35 $33,232 - $52,554	6,294 Added 5.08%	130,307 $962,000
Q1 2023 May 11, 2023	SELL	$7.6 - $12.68 $9,142 - $15,254	-1,203 Reduced 0.96%	124,013 $1.01 Million

Q4 2022 Feb 13, 2023	BUY	$8.6 - $14.1 $20,210 - $33,135	2,350 Added 1.91%	125,216 $1.2 Million
Q3 2022 Nov 14, 2022	BUY	$10.63 - $15.76 $566,951 - $840,559	53,335 Added 76.71%	122,866 $1.44 Million
Q2 2022 Aug 15, 2022	BUY	$8.38 - $12.85 $17,849 - $27,370	2,130 Added 3.16%	69,531 $894,000
Q1 2022 May 13, 2022	BUY	$9.84 - $14.97 $71,271 - $108,427	7,243 Added 12.04%	67,401 $741,000
Q4 2021 Feb 11, 2022	BUY	$11.37 - $15.31 $152,267 - $205,031	13,392 Added 28.64%	60,158 $922,000
Q3 2021 Nov 16, 2021	SELL	$13.04 - $21.0 $48,978 - $78,876	-3,756 Reduced 7.43%	46,766 $653,000
Q2 2021 Aug 16, 2021	BUY	$17.89 - $26.05 $903,838 - $1.32 Million	50,522 New	50,522 $978,000

Others Institutions Holding AKYA

# of Institutions

Shares Held

14.9M

Call Options Held

71.9K

Put Options Held

View Full List

About Akoya Biosciences, Inc.

Ticker AKYA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,892,300
Market Cap $88.7M
Description
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...

More about AKYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Akoya Biosciences, Inc. Transaction History